Colgate-Palmolive Company reported better-than-expected second quarter results on Friday, with shares rising 1.4% following the announcement as both earnings and revenue surpassed analyst expectations ...

Colgate-Palmolive surpasses Q2 expectations with $5.11B revenue, doubling down on retail productivity, supply chain agility, ...

Colgate-Palmolive Company (NYSE:CL) is brushing up its future with a bold 2030 plan, even as it takes on up to $300M in ...

American consumer products giant Colgate-Palmolive beat analysts' estimates with improved second-quarter results, though the stock flatlined after the company delivered a cautious outlook and ...

Colgate-Palmolive said it needs to further raise prices and adjust product sizes to hit the low end of its full-year organic ...

Good morning. Welcome to today's Colgate-Palmolive 2025 Second Quarter Conference Call. This call is being recorded and is being simulcast live at www.colgatepalmolive.com. Now for opening remarks, ...

Detailed price information for Colgate-Palmolive Company (CL-N) from The Globe and Mail including charting and trades.

Colgate-Palmolive beat first-quarter sales and profit estimates on Friday, as resilient demand for its essentials such as ...

Analysts expect Colgate-Palmolive to report an earnings per share (EPS) of $0.89. Investors in Colgate-Palmolive are eagerly ...

Colgate-Palmolive's forward PE ratio is 22.48 compared to Procter & Gamble's 18.84 and Unilever's 19.30, indicating that Colgate-Palmolive is over-priced relative to its peers.

Colgate Palmolive’s net sales for the first nine months of 2012 stood at $2.3 billion, up more than 2% over the previous year. This growth was largely driven by a robust 6.5% increase in organic ...